Will the Phase 3 trial "A Clinical Study on the Treatment of LACC With Cadonilimab Combined With Chemotherapy Followed by CCRT" reach primary completion on or before Jul 18, 2028?

Resolves Yes if ClinicalTrials.gov record NCT07400536 (Union Hospital, Tongji Medical College, Huazhong University of Science and Technology) shows an actual primary completion date on or before Jul 18, 2028. Registered date at generation: Jul 18, 2028.

Outcome verified from clinicaltrials.gov.

1. Market open

   Jul 17, 2026, 7:40 AM UTC
2. Market closes

   By Jul 18, 2028, 11:59 PM UTC
3. Projected payout

   Shortly after the market closes

Trading on material non-public information is prohibited. Markets are for entertainment and informational purposes using free Pulse Credits — no real-money wagering. If you believe a participant has acted on inside information, please report it.